Project Description

This is one of the biggest cohort ATUs in metastatic breast cancer with more than 700 women in 12 months receiving an innovative treatment prior to marketing authorisation. Axonal-Biostatem has set up an ATU cell for managing the requirements of treatment multiple times a day (pre-validation of treatment eligibility criteria, transmission […]